UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Doctor fuels controversy with YouTube advice on how to take dog dewormer
Recently, several cancer patients were admitted to university hospitals due...
by Lee Hye-seon
|
2019-11-18 16:47
라인
KDA, KBR team up for global promotion of Korean medicine
Korean Diabetes Association (KDA), Korea’s first healthcare-focused English...
by Lee Hye-seon
|
2019-11-08 14:09
라인
Regulator allows easier access to clinical trial participation, inquiry
The regulator said it would allow patients and guardians to check with info...
by Lee Hye-seon
|
2019-10-24 15:36
라인
Drug regulator to hire 87 more reviewers next year
The Ministry of Food and Drug Safety said it would add 87 staff for the rev...
by Lee Hye-seon
|
2019-10-11 16:35
라인
Allergan Korea to replace breast implant without time limit
Allergan Korea CEO Kim Ji-hyun said she would lift the two-year time limit ...
by Lee Hye-seon
|
2019-10-08 15:22
라인
Civic group protests regulator’s inaction over insulin pumps FDA recalled
A civic group supporting diabetic patients said it would hold a rally to pr...
by Lee Hye-seon
|
2019-10-07 16:10
라인
‘New law to support advanced biopharmaceuticals, ensure safety’
The Ministry of Food and Drug Safety is preparing to implement the “Act on ...
by Lee Hye-seon
|
2019-10-04 15:18
라인
Authorities to test drugs of ranitidine family for carcinogen risk
The Ministry of Food and Drug Safety said it might test all stomach medicin...
by Lee Hye-seon
|
2019-10-02 14:51
라인
Allergan to compensate breast implant recipients for damage
Allergan agreed to provide full compensation for the medical expenses of pa...
by Lee Hye-seon
|
2019-09-30 15:33
라인
Sale of Novartis’ conjunctivitis drug Pataday banned for 3 months
The Ministry of Food and Drug Safety has suspended the sale of Novartis Kor...
by Lee Hye-seon
|
2019-09-30 11:25
라인
Ranitidine heartburn drugs banned due to carcinogen risk
The Ministry of Food and Drug Safety has suspended the manufacturing and se...
by Lee Hye-seon
|
2019-09-26 13:32
라인
Ministry to announce results of ranitidine testing for carcinogen
The government is likely to announce the results of the test on ranitidine ...
by Lee Hye-seon
|
2019-09-25 14:46
라인
Indian biosimilar of rituximab to undergo test in Korea
India’s largest generics drugmaker Dr. Reddy's Laboratories said it wou...
by Lee Hye-seon
|
2019-09-19 10:31
라인
Regulator inspects heartburn drugs after US finds carcinogen
After U.S. health officials said they detected low levels of a potentially ...
by Lee Hye-seon
|
2019-09-16 14:01
라인
Lilly’s migraine treatment Emgality lands in Korea
Lilly’s new migraine treatment Emgality Prefilled Pen Inj. (ingredient: gal...
by Lee Hye-seon
|
2019-09-05 16:24
라인
Multiple myeloma treatment isatuximab named orphan drug
The drug regulator designated isatuximab, a treatment for relapsed and refr...
by Lee Hye-seon
|
2019-09-03 11:21
라인
SK Biopharmaceutical’s sleepiness drug initially aimed to treat depression
Sunosi (ingredient: solriamfetol), a treatment for narcolepsy developed by ...
by Lee Hye-seon
|
2019-08-22 15:37
라인
‘Ministry to provide quick measures for users of Allergan’s breast implants’
Fear is spreading among Korean women who received Allergan’s specific breas...
by Lee Hye-seon
|
2019-08-21 15:20
라인
Combo drugs: latest trend in local pharmaceuticals
Domestic pharmaceutical companies are actively developing combination drugs...
by Lee Hye-seon
|
2019-08-19 16:02
라인
Rare cancer reported in Korea regarding Allergan’s breast implant
The health authorities said here they have received the first report of bre...
by Lee Hye-seon
|
2019-08-16 14:54
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top